Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学ctDNA-Guided Adjuvant Selection NSCLC

Charu Aggarwal

MD, MPH

🏢University of Pennsylvania Abramson Cancer Center🌐USA

Leslye M. Heisler Associate Professor for Lung Cancer Excellence

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Charu Aggarwal leads research on ctDNA-based minimal residual disease detection to guide adjuvant therapy selection in resected NSCLC. Her work on MERMAID and related trials tests escalation strategies for ctDNA-positive patients after surgery. She has helped define the clinical utility of tumor-informed ctDNA assays in early-stage lung cancer.

Share:

🧪Research Fields 研究领域

ctDNA MRD NSCLC
adjuvant selection by ctDNA
ctDNA surveillance post-resection
ctDNA personalized therapy
LUNAR-2 MERMAID trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Charu Aggarwal 的研究动态

Follow Charu Aggarwal's research updates

留下邮箱,当我们发布与 Charu Aggarwal(University of Pennsylvania Abramson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment